REGERNA
pharmaceutical preparations for the treatment and diagnosis of neuromuscular and musculoskeletal diseases, conditions, and disorders, muscular dystrophies, genetic diseases, conditions, and disorders, muscle-loss diseases, conditions, and disorders, and traumatic injuries; pharmaceutical preparations in the nature of gene therapy and gene delivery therapeutics; medicines for muscle and neuromuscular junctions and regeneration
Pending · September 7, 2023 · 98169954 ·
